Contact PR

To use this feature, join Babbler easily !


Babbler allows PR people and reporters to collaborate a better way.

By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.

Their newsrooms are already on Babbler

You're 1 click away from signing up


Nice to see you again !

Press release

Uterine Fibroids Market - The Biggest Trends to look out for 2017-2022
timer minutes reading time minute reading time

Copy link

Click to get original image size

The U.S. Uterine Fibroids Market report explores the Top Key Players in-depth analysis as

Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. 

Uterine fibroids is spreading over U.S. at a steady pace due to its high prevalence in African- American race. The exact cause of uterine fibroids is unknown, however heredity of uterine fibroids, high blood pressure and low levels of vitamin D are some of the major causing factors of uterine fibroids. Based on the market scenario, it has been observed that procedures like hysterectomy and myomectomy are majorly covering the Uterine Fibroid treatment market despite of their side effects, which as a result is showcasing the limited treatment options for UF. 

The U.S. Uterine Fibroid Market has been evaluated as a growing market and it is expected that the market will touch high growth figures. The increasing prevalence of uterine fibroids and growing number of hysterectomy surgeries every year in this region are some of the factors driving the market for this disease. There are several other treatment options available now a days in U.S. that are driving the overall uterine fibroids market such as self-help techniques, pharmacotherapy, uterine artery embolization and invasive surgical procedures (myomectomy & hysterectomy). The U.S. Uterine Fibroids market is expected to reach USD 39,993.2 million in 2022.

Key Finding

  • The U.S. Uterine Fibroid Market and is expected to reach USD 39,993.2 million by 2022.
  • By Type, Intramural Fibroids holds the largest market share of U.S. Uterine Fibroid Market and is expected to reach USD 14,972.5 million by 2022.
  • By Treatment, hysterectomy holds the largest market share of U.S. Uterine Fibroid Market and is expected to reach USD 8,042.3 million by 2022.

Key Players:

AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.) and others.

Get Sample Copy @ .

U.S. Uterine Fibroid Market:

In the coming years, it is expected that the U.S. Uterine fibroid Market will advance with higher growth rate as compared to previous years. The large number of women affected by the problem and the large number of hysterectomy procedure are done to treat the symptoms are the major factors driving the market for uterine fibroid market.


U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.

Regional Analysis:

The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. Treatment with both drug and surgery accounted for the largest market share by treatment while treatment with only surgery is the second largest market for uterine fibroid, by treatment. Treatment with only pharmacotherapy is the fastest growing market, which is expected to grow at a CAGR of 18.96% during the forecast period of 2016-2022. The reason for this high growth is the positive clinical trial results of some drugs which will shoot the uterine fibroid market for pharmacotherapy.  

Brief TOC:

Topic 1 Introduction  

1.1.1 Prevalence of the Uterine Fibroids in U.S. 8

Topic 2 Scope of Study

2.1 Research Objective 10

2.2 Assumptions & Limitations 10

2.2.1 Assumptions 10

2.2.2 Limitations 10

2.3 Market Structure 11

Topic 3 Research Methodology

3.1 Primary Research 13

3.2 Secondary Research 13

Topic 4 U.S. Uterine Fibroid Market

4.1 Introduction 15

4.2 U.S. Uterine Fibroid Market, By Type 17

4.3 U.S. Uterine Fibroid Market, By Diagnosis 19

4.4 U.S. Uterine Fibroid Market, By Treatment 21


Ask to Expertise @ .

Top Reasons to Buy the Reports:

Company profiling with detailed strategies, financials, and recent development activities 

Market Strategic Business Influence Data

Market Research Future recommendations in key business segments based on the market estimations 

Market share analysis of the top industry players 

Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Market Research Future

+1 646 845 9312


  • Health & Medicine
  • Medicine
inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here

  • Health & Medicine
  • Medicine